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Abstract
Background:  Accumulating databases in human genome research have enabled integrated
genome-wide study on complicated diseases such as cancers. A practical approach is to mine a
global transcriptome profile of disease from public database. New concepts of these diseases might
emerge by landscaping this profile.
Methods: In this study, we clustered human colorectal normal mucosa (N), inflammatory bowel
disease (IBD), adenoma (A) and cancer (T) related expression sequence tags (EST) into UniGenes
via an in-house GetUni software package and analyzed the transcriptome overview of these
libraries by GOTree Machine (GOTM). Additionally, we downloaded UniGene based cDNA
libraries of colon and analyzed them by Xprofiler to cross validate the efficiency of GetUni. Semi-
quantitative RT-PCR was used to validate the expression of β-catenin and. 7 novel genes in
colorectal cancers.
Results: The efficiency of GetUni was successfully validated by Xprofiler and RT-PCR. Genes in
library N, IBD and A were all found in library T. A total of 14,879 genes were identified with 2,355
of them having at least 2 transcripts. Differences in gene enrichment among these libraries were
statistically significant in 50 signal transduction pathways and Pfam protein domains by GOTM
analysis P < 0.01 Hypergeometric Test). Genes in two metabolic pathways, ribosome and glycolysis,
were more enriched in the expression profiles of A and IBD than in N and T. Seven transmembrane
receptor superfamily genes were typically abundant in cancers.
Conclusion:  Colorectal cancers are genetically heterogeneous. Transcription variants are
common in them. Aberrations of ribosome and glycolysis pathway might be early indicators of
precursor lesions in colon cancers. The electronic gene expression profile could be used to
highlight the integral molecular events in colorectal cancers.
Background
Worldwide, the incidence of colorectal cancer has been
rising nowadays. It is the second mortality caused by can-
cers in western countries and the third or fourth in China
[1]. Many tumor suppressor genes, oncogenes, and
growth factor genes have been demonstrated to be
involved in the carcinogenesis of colon and rectum, for
example, k-ras, APC, p53 and TGFβ. A molecular genetic
model of multiple genes and steps was proposed by
Vogelstein in 1990 [2]. Two paralleling molecular path-
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ways, mutator pathway and chromosomal instability
pathway, were accepted since the identification of micro-
satellite instability (MSI) in hereditary non-polyposis
colorectal cancer (HNPCC) in 1993 [3]. Four precursor
lesions of colorectal cancers, adenoma, inflammatory
bowel disease (ulcerous colitis and Crohn's disease), juve-
nile polyp and hyperplastic polyp, were mentioned in the
latest edition of WHO tumour classification of digestive
tract [1]. However, molecular understanding of colorectal
cancer remained in its infancy. An emerging principle is
that malignant transformation of colonic epithelial cells
does not merely rely on mutations of generic oncogenes
or tumour suppressor genes. It seems that the altered
interactions among multiple genes or regulatory pathways
might specifically subvert the physiological regulators of
the epithelium [4]. The finished human genome was
released last October in which only 20,000~25,000 genes
in the human genome were estimated, far less than
expected previously [5]. This also suggests that the interac-
tions among genes or transcription level of genes really
matters in both physiological and pathological processes
including carcinogenesis. Hence, an integrated study on
the genome-wide gene expression profile is necessary to
build the corresponding gene networks underlying com-
plicated diseases, such as colorectal cancers [6].
Experimental and computational approaches are most
commonly used strategies in large-scale gene expression
studies [7]. The former was represented by cDNA or serial
analysis of gene expression (SAGE) library and recently
developed gene expression microarray. The latter consists
of various data mining methods from public database
including digital differential display (DDD) in non-nor-
malized cancer genome anatomy project (CGAP) libraries
and digital Northern-blot in National Cancer Institute
(NCI) SAGEMap [8,9].
Expression sequence tags (ESTs) are single passed, frag-
ments of complementary DNA (cDNA) clones from dif-
ferent libraries. They are efficient for discovering novel
genes in the genome [10]. It is estimated that at least
10,000 different genes are expressed in a cell with an aver-
age of about 30,000 mRNA molecules per cell. Hence, an
EST library, even constructed by various modified meth-
ods such as suppression subtraction hybridization (SSH)
and representational differential display (RDA), is no
more than a snapshot of the mRNA composition of a cer-
tain tissue at a certain time. Particularly, genes in low-
abundance might not be well represented. Fortunately,
ESTs of one tissue from different libraries were available
via three international nucleic acid databases, GenBank,
EMBL and DDBJ. The total number of ESTs in these data-
bases amounted to an unprecedented figure especially in
the process of the initial and finished human genome
sequences. Additionally, these ESTs are automatically par-
titioned into UniGene cluster, a non-redundant set of
gene-oriented clusters [11]. Each UniGene cluster might
represent one gene or at least one gene transcript. Thus,
UniGene was widely applied in gene mapping, large scale
gene expression, and gene alternative splicing variants
identification. Therefore, it is a practical approach to mine
a global transcriptome profile for a specific tissue in a cer-
tain physiological or pathological state from public data-
bases [12].
In this study, we scrutinized the ESTs of colorectal tissues
under 4 different states including normal mucosa (N),
colorectal cancers (T), and two most common precancer-
ous lesions: adenoma (A) and inflammatory bowel dis-
ease (IBD, ulcerative colitis and Crohn Disease included).
Transcriptome maps of these four tissues were constructed
via an in-house GetUni software package. To our knowl-
edge, the current study is the first transcriptome map of
colorectal cancers mining from NCBI EST database
(dbEST) up to now. Genes in the maps were pathway ori-
ented and analyzed by WebGestalt (WEB-based GENE SeT
AnaLysis Toolkit). Several novel conceptions in colorectal
tumours were emerging including heterogeneity in color-
ectal cancers, potential role of metabolic alterations in
ribosome and glycolysis pathway in cancer precursor
lesions, frequent variant transcripts in colorectal cancer as
well as several novel genes in colorectal tumourigenesis,
thus facilitate the understanding of molecular mecha-
nisms underlying colorectal cancer development.
Methods
Resources for databases and computer programs
Human colorectal normal (N), IBD, adenoma (A) and
cancer (T) associated electronic EST libraries were down-
loaded from dbEST [13] using keywords "(homo sapiens
OR human) AND (colon OR rectal OR colorectal OR large
bowel) AND normal AND gbdiv_est [PROP]", "(homo
sapiens OR human) AND (colon OR rectal OR colorectal
OR large bowel) AND (inflammatory bowel disease OR
Crohn's disease OR ulcerative colitis) AND gbdiv_est
[PROP]", "(homo sapiens OR human) AND (colon OR
rectal OR colorectal OR large bowel) AND adenoma AND
gbdiv_est [PROP] AND gbdiv_est [PROP]" and "(homo
sapiens OR human) AND (colon OR rectal OR colorectal
OR large bowel) AND (cancer OR carcinoma OR adeno-
carcinoma) AND gbdiv_est [PROP]", respectively. Human
UniGene database (hs.data, build#181) was also down-
loaded from NCBI UniGene repository [14].
GetUni software package (available upon request), an in-
house potent computational approach for clustering non-
redundant nucleotide into UniGenes, was written in
Perl6.0 and run under Linux (Redhat 9.0) operating sys-
tem. The basic analytic scheme is depicted below: firstly,
extract accession number from the non-redundantBMC Cancer 2006, 6:40 http://www.biomedcentral.com/1471-2407/6/40
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sequence; secondly, export related UniGene information
from the downloaded UniGene database via accession
number; then remove the redundant UniGene informa-
tion and automatically record the hits of identical Uni-
Gene; and finally, obtain the expression profile via gene
symbol for each electronic EST library.
Additionally, the cDNA libraries of colon mucosa, inflam-
matory bowel disease, adenoma and cancer were also
downloaded from UniGene based cDNA expression pro-
filer and analyzed by the online tool Xprofiler [15]. Genes
in these libraries were applied as controls to cross validate
the results from our in-house GetUni software package.
Analysis of the transcriptome in colorectal tissues
GOTM is a web-based platform for interpreting interest-
ing gene sets including microarray data using Gene Ontol-
ogy hierarchies [16,17]. It provides classification and
tissue distribution of genes as well as analytical tools
(WEB-based GEne SeT AnaLysis Toolkit, WebGestalt) for
comparison of the significantly enriched gene numbers in
the catalogue of gene ontology in a pathway- or gene fam-
ily- oriented way between an interesting and a reference
gene set. A reference gene set might include all the genes
in the human genome or another appropriate gene set.
Hypergeometric test, appropriate for sampling without
replacement, was adopted by GOTM to determine
whether those enrichments are statistically significant.
Since gene classification in GOTree is comprehensive and
complex, we adopted genes at the default level 4 as the
final export results.
Semi-quantitative RT-PCR
In order to validate these putative genes, we selected β-cat-
enin and 7 novel genes, which were rarely studied in
colorectal cancers, for semi-quantitative RT-PCR analysis
in 10 colorectal cancer tissues with matched normal
mucosa and 6 colon cancer cell lines (SW620, Hce8693,
Caco2, SW480, HT29, and RKO). These 7 putative genes
were TWISTNB (TWIST Neighbour), SOX9 [SRY (sex
determining region Y)-box 9 (campomelic dysplasia,
autosomal sex-reversal)], YPEL2 [Yippee-like 2 (Dro-
sophila)], YPEL5 [Yippee-like 5 (Drosophila)], SEPT4
(Septin 4), SEPT6 (Septin 6) and CBX3 [Chromobox
homolog 3 (HP1 gamma homolog, Drosophila)].
GAPDH (Glycer aldehyde 3 phosphate dehydrogenase)
was used as an internal control to normalize samples. The
primers and amplification conditions of these genes are
listed in Table 1. Ten microliters of PCR products were
added on a 1.8% TBE agarose gel. Band intensities were
measured by BioRad Quantity One Image Analysis Soft-
ware. The ratio of target genes versus GAPDH in band
intensity was further calculated and compared.
Results
Transcriptome comparison among the gene expression 
profiles of N, IBD, A and T
As shown in Figure 1, there are 20,370, 3,824, 1,270 and
279,163 ESTs in libray N, IBD, A and T, respectively. Using
the in-house GetUni software, we could only cluster
10,458, 3,451, 875 and 200,608 ESTs into 4,375, 2,230,
606 and 18,891 UniGene transcripts, and eventually got
4108, 2201, 592 and 14879 genes in N, IBD, A and T
libraries, respectively. ESTs which failed to be clustered
into UniGene might be due to their poor quality rather
than novel ESTs beyond UniGene database as we noted
that most of them were genomic or mitochondria DNA
fragments. The average ESTs in individual transcript were
4.66, 1.71, 2.15 and 14.78 for N, IBD, A, and T, respec-
tively, reflecting that EST redundancy was increased with
EST total sums in the library. Meanwhile, we found that
2,355 genes have at least 2 transcripts. Particularly, in the
Table 1: Primers and amplification conditions of 8 selected putative genes
Gene Name Primers PCR Fragments (bp) Annealing Temperature(C) Cycles
TWISTNB ATAACATCAAAGTTGTGGGAGA 196 48 35
TCAGGTTTAGGAATGGAGGC
YPEL2 ATCGAAGACTTTCCAGGCATAT 344 57 36
ATCAGTCCCAGCCATTGTCC
YPEL5 TAAACCTGGAGACTCGGGTGG 205 59 35
AGCGGTTGGTCAGGATCGTAT
Sep6 AAGGTTGCCGAACTGTCC 280 59 36
AAGCCAACTGTGCTAACGA
Sep4 CGAAAGTCCGTGAAGAAAG 221 59 34
GTGTCCACAATGGTGAGCC
CBX3 ATAATTGGTGCCACAGACA 325 53 31
AACAACTCTTCCAACGCTA
SOX9 AGGTGCTCAAAGGCTACGACT 360 63 32
AGATGTGCGTCTGCTCCGTG
β-catenin TCTTGGCTATTACGACAG 459 58 32
CCTCTATACCACCCACTTBMC Cancer 2006, 6:40 http://www.biomedcentral.com/1471-2407/6/40
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expression profile of T, the average transcripts of each
gene reached to 1.27, significantly higher than in N, A and
IBD (P < 0.01, χ2 test). Surprisingly, all the genes and Uni-
Gene transcripts from A, N, and IBD libraries were found
in the T library with the only exception of a transcript
(Hs.329040, bA9F11.1, a hypothetical protein) which
was only found in A library. Overlapping genes were com-
mon among N, IBD and A library (see Figure 2). Intrigu-
ingly, we also noted a considerable part of novel ESTs in
these electronic libraries. There were 237 (5.42%, 237/
4375), 65 (2.91%, 65/2230), 11 (1.82%, 11/606) and
5198 (27.52%, 5198/18891) novel ESTs in library N, IBD,
A and T, respectively. A significant correlation between
novel ESTs and total UniGene transcripts was revealed (p
= 0.011, rho = 1, Spearman correlation).
GOTM analysis demonstrated that the general gene distri-
bution was similar at level 4 in the biological processes
among N, IBD, and A. Genes associated with these proc-
esses of primary metabolism, cellular metabolism, macro-
molecule metabolism and signal transduction were most
enriched. Genes in these processes might be closely asso-
ciated with the colon-specific function of differentiation.
However, as for cancers, genes associated with these proc-
esses of cell growth and/or maintenance, macromolecule
metabolism, nucleobase/nucleoside/nucleotide and
nucleoacid metabolism and signal transduction were
most frequently present (see Figure 3). In reference to the
total genes of the whole human genome, genes in the bio-
logical processes as mentioned above were all signifi-
cantly enriched in cancers except those in the process of
signal transduction, implying the potentially pivotal and
relatively specific role of these biological processes in the
physiology and tumourigenesis of colon. We also classi-
fied genes in the 4 profiles of N, IBD, A, and T into 302,
269, 135 and 314 Biocarta pathways, or 131, 127, 87 and
144 KEGG pathways, or 525, 383, 178 and 1573 Pfam
protein domains, respectively (See Additional file 1, 2, 3,
4). Totally, genes in 50 pathways and Pfam domains were
significantly enriched in one library as compared with
another (Hypergeometric Test, P < 0.01) (See Additional
file 5). Of note, A and IBD shared enriched genes in ribos-
ome or glycolysis pathway whereas T had enriched genes
of 7 transmembrane receptor family (rhodopsin family).
Total ESTs, UniGene transcripts, and Genes in 4 colorectal libraries Figure 1
Total ESTs, UniGene transcripts, and Genes in 4 colorectal libraries. The number 1, 2, 3 and 4 in the X-axis stand for total 
ESTs, validated ESTs that could be clustered in to UniGene, UniGene transcripts and genes, respectively. The exact counts of 
each category in different states are shown in the Y-axis. Z-axis reflects different status in colon, i.e., normal (N), inflammatory 
bowel disease (IBD), adenoma (A) and colorectal cancer (T) as indicated by different colours in the figure. This figure implies 
that the increased ESTs in these libraries might be positively associated with gene redundancy in these profiles.BMC Cancer 2006, 6:40 http://www.biomedcentral.com/1471-2407/6/40
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Comparison of these dbEST profiles with those of UniGene 
cDNA Libraries
A total of 134 cDNA libraries of colon were identified in
the UniGene cDNA based expression profiler. Neverthe-
less, we only found 32 with definite histology diagnosis
including colon mucosa 4 (i.e. normal, N), IBD 2, ade-
noma (A) 1 and cancer or tumour (T) 25. Using the online
tool Xprofiler, we obtained 5274, 2234, 588 and 13071
UniGnene transcripts, or 5032, 2111, 566 and 11162
known genes in these UniGene library N, IBD, A and T.
More than 98% genes in the UniGene based expression
profile IBD, A and T were included in our corresponding
libraries, respectively, in support of the potency of our
GentUni software package. The minor discrepancy might
reflect the updated UniGene database. We have to admit
that a relatively greater gap existed between the two N pro-
files of the UniGene based libraries and ours since only
70% genes in UniGene N profile was identified in ours.
We noticed that the annotation of these so-called normal
libraries in UniGene database were "colon mucosa", not
"NORMAL". Considering the stringent keywords that we
used in this study, it is not strange that all these libraries
were not included in our N library downloaded from the
dbEST. Actually, it is inevitable that missing data could
occur in any data mining studies. Fortunately, genes in the
UniGene based N profile were included in our T library.
Expression of 8 putative genes in colorectal cancers by RT-
PCR
In this electronic profile of colorectal cancer, we acquired
numerous genes which were typically involved in colorec-
tal carcinogenesis including mucin related genes, keratins,
colon differentiation-related genes, tumour suppressor
genes, cell cycle genes, telomerase and regulated genes,
proliferation and apoptosis associated genes, etc (data not
shown). More importantly, many genes, which were
rarely reported in colorectal cancers, were also included.
Here, we amplified 7 of such novel genes and the well-
known β-catenin as a positive control. RT-PCR showed
that all 8 genes were successfully amplified in colorectal
tissues and cancer cells, confirming their expression in
colorectal cancers, although they were not expressed in all
tissues. Upregulation in cancers was seen in TWISTNB 4,
YPEL2 3, CBX3 3, SOX9 8 and β-catenin 7, while down-
regulation was seen in TWISTNB 6, YPEL2 1, YPEL5 3,
SEPT4 2, SEPT6 4, CBX3 3, SOX9 2 and β-catenin 2, com-
pared with those in normal mucosa. The expression level
in the remaining cases kept unchanged or was absent. All
6 cell lines expressed YPEL2, YPEL5, TWISTNB, CBX3,
SOX9 and β-catenin. SEPT4 expression was absent in
SW620 and RKO while SEPT6 expression was undetected
in RKO. It was noteworthy that SOX9 was upregulated in
most cancers and expressed in all 6 cell lines, in accord-
ance with that of β-catenin (Figure 4).
Discussion
The release of the human genome sequences and accumu-
lating databases as well as technological development for
detecting large-scale gene expression profile have enabled
integrated genome-wide study on complicated pathologi-
cal states, such as cancers. Tissue or organ-specific gene
expression patterns as well as genome mapping have been
reported via database mining including dbEST and
SAGEMap [12,18]. These computational methods were
proved to be effective for comparisons among tissues
under different physiological or pathological states [19].
We thus developed an integrated dbEST mining proce-
dure, GetUni. In this study, we utilized GetUni for
genome-wide transcriptome analysis on normal mucosa,
cancers and related precancerous lesions of colon. The
efficiency of this software package was cross validated by
the profiles of UniGene cDNA based libraries using the
Xprofile online tool. However, we did not focus on differ-
ential gene expression patterns among these states since
Comparison of gene distribution in 4 gene expression pro- files Figure 2
Comparison of gene distribution in 4 gene expression 
profiles. As depicted in the figure, area within the red, 
green, blue and grey circle is representative for the profile of 
N (normal), IBD (inflammatory bowel disease), A (adenoma) 
and T (cancer), respectively. Genes in A, IBD and N were all 
found in T, implying heterogeneity of colorectal cancer. 
Overlapping areas as filled by different colours are inter-
preted as the common genes among profiles. For example, 
the black area means the coexpressed genes in N, IBD and A, 
and the number "186" on it represents the total of related 
genes.BMC Cancer 2006, 6:40 http://www.biomedcentral.com/1471-2407/6/40
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ESTs from dbEST were made by various methods by con-
tributors. To our knowledge, this is the first report on
computational genome-wide transcriptome analysis.
In the initial analysis of these 4 sets of transcriptome, we
noticed a prominent phenomenon that all genes or gene
transcripts from N, IBD and A were found in cancers.
Besides the fact that the total ESTs in T were much more
than those in the other 3 libraries, one of the underlying
paradoxical interpretations was the complicated heteroge-
neity of colorectal cancers with regard to histogenesis,
morphology and molecular genetics, etc. ESTs were highly
redundant cDNA fragments derived from either the 3'- or
5'- regions of human genes. For example, there were
20,370 and 279,163 ESTs, and finally 4,108 and 14,879
genes in N and T library, respectively. The average ESTs per
gene between T and N (18.7622, 279,163/14,879 versus
4.9586, 20,370/4,108) was approximately 5 and
amounted to 7 after normalization of EST clustering effi-
ciency (51.34% in N versus 71.86% ESTs in T which could
be clustered into UniGenes, respectively). Considering
that there are about 13 times more ESTs in T than in N, it
is reasonable to believe that at least 50% increased ESTs in
T library could be ascribed to redundancy, suggesting that
increased EST was not the unique answer for the broad
pattern of gene expression in cancers. Multiple pathways
contributing to colorectal cancers were well established
including adenoma-carcinoma sequence, inflammatory
bowel disease-dysplasia-cancer, hyperplastic polyposis-
intraepithelial neoplasia (IEN)-cancer or juvenile polypo-
sis-IEN-cancer as well as direct malignant transformation
from normal mucosa (de novo) [1]. As for morphological
features, various histological subtypes with varied differ-
entiation were fully accepted including tubular adenocar-
cinoma, mucinous carcinoma, signet-ring cell carcinoma,
medullary carcinoma, undifferentiated carcinoma, etc. A
long standing concept in cancer biology is that tumours
arise and grow as a result of "tumour stem cells" or "stem
cells" (multipotent progenitor cells with the capacity for
self-renewal) with multiple additional mutations [20].
Consistent with this idea, a defined minority of these cells
might be able to proliferate, differentiate, dedifferentiate
and transdifferentiate, resulting in heterogenous gene
expression patterns in cancers.
This study also found that transcript variants were quite
common since 2,355 out of 14,879 genes had at least 2
transcripts. And, we believe that with the ever increasing
ESTs in dbEST, more transcript variants would be discov-
ered in these colonic tissues. In the finished human
genome, a big surprise is that there are not more than
25,000 genes in the human genome, barely more than the
worm Caenorhabditis elegans [5]. Considering the myriad
cellular processes that keep our body functioning, a clear
and reinforcing realization is that many genes encode
more than one protein, a theory replacing the old notion
of one gene one protein. One way that human genome
performs such complex functions with so few genes is
alternative splicing, which plays important roles in devel-
opment, physiology, and disease. A genome survey of
human alternative pre-mRNA splicing indicated that at
least 74% of human multi-exon genes are alternatively
Level 4 categories under biological_process in the T library as compared with the total genes in the whole human genome Figure 3
Level 4 categories under biological_process in the T library as compared with the total genes in the whole 
human genome. Red bar: genes in T (colorectal cancer) library; Blue bar: whole genes in the human genome. The different 
biological categories are labeled along the X-axis and the gene numbers in each catalogue are in the Y-axis. Catalogues with sig-
nificantly enriched gene numbers is indicated by red words as compared with genes in the whole human genome (p < 0.01, 
Hypergeometric test).BMC Cancer 2006, 6:40 http://www.biomedcentral.com/1471-2407/6/40
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spliced [21]. Furthermore, another intriguing phenome-
non in this preliminary study is that the average tran-
scripts of individual gene in T are higher than those in the
other profiles, indicating that increased alternative splic-
ing might be an optimal option for colorectal cancer con-
sidering their more complicated biological behaviours
and functions than those of normal or benign lesions in
colon tissue.
Uexpectedly, the enriched genes of ribosome in KEGG
pathway were highest in 2 precancerous lesions, A and
IBD, and lowest in cancer as suggested by GOTM analysis
when we compared among these 4 libraries. Ribosome
proteins, the major components of ribosome which is the
protein synthesis center in a cell, play critical roles in
physiological and pathological situations. The fundamen-
tal physiological function of colonocytes is secretion,
which involves many ribosomes, as evidenced by elec-
tronic microscopy. In addition, there is highly active
renewal and proliferation in crypt cells. But in cancer, this
secretary capability was lost or or impaired due to dedif-
ferentiation, resulting in the limited enrichment of ribos-
ome genes in cancers despite that other oncogenic
proteins might be actively synthesized with the absolute
number of ribosome genes remaining high. This hypoth-
esis was supported by a recent immunohistochemical
study, in which 10 of 12 ribosome proteins were stained
stronger in normal mucosa than in colon cancers [22]. As
in adenoma and IBD, 2 intermediate states between nor-
mal mucosa and cancers, we hypothesized that the ability
of secretion largely remained and that there was addi-
tional new protein synthesis to maintain the transformed
phenotype in IEN or dysplasia. In our previous analysis
on differentially expressed genes between colonic ade-
noma-normal mucosa, 6 out of 62 differentially expressed
genes were ribosome proteins [23]. Ribosome protein S11
and L7 were upregulated in colonic adenomas rather than
in normal mucosa or cancers as indicated by microarray
[24]. An early study also demonstrated that increased
mRNA levels of several ribosomal proteins were present in
colorectal tumors and polyps [25]. All these findings
implicated that increased synthesis of ribosomes might be
an important indicator of precursor lesions of colorectal
cancers.
Other findings in this study were also intriguing. Genes in
the process of the KEGG Glycolysis/Gluconeogenesis
pathway were significantly more enriched in adenomas
and IBD than in cancers. This is consistent with a recent
report on ApcMin/+ mouse model of colon tumours (26).
Aberrant glucose metabolism might be emerged in the
precancerous stage, earlier than before expected. Five
thioredoxin family members were present in library A.
These enriched genes might play important roles in anti-
oxidative injury, inhibition of apoptosis, cell proliferation
and differentiation [27,28]. Totally, 111 7-transmem-
brane receptor (rhodopsin family) superfamily members
were found in cancers. Small GTP-binding protein-cou-
pled receptors, endocrinal or neuroendocrinal receptors,
and cytokine receptors were included in this catalogue.
Their role in colon cancer was well documented recently
[29,30].
Finally, we analyzed the expression of 8 putative genes in
colorectal cancers. The preliminary data suggested that all
these genes were variably expressed in cancer tissues and
cell lines. Particularly, SOX9 was upregulated in most
colorectal cancers. It is in consistent with our latest immu-
nostaining results (unpublished data), indicating that
SOX9 may play oncogenic roles and serve as an independ-
ent adverse prognosticator in colorectal cancers. A recent
study revealed that SOX9 was an intestinal crypt specific
Expression of SOX9 and β-catenin in colorectal cancers Figure 4
Expression of SOX9 and β-catenin in colorectal cancers. Semi-quantitative RT-PCR shows SOX9 and β-catenin 
expression in colorectal cancer tissues (Left) and cell lines (Right). Representative names of each sample or cell line are listed 
under the figure. T stands for cancer tissue and N for matched normal colonic mucosa. GAPDH is used as the normalization 
control and given at the bottom of the figure. Up-regulation of SOX9 and β-catenin is present in case 1, 2, 3, 4 and 6, and 
down-regulation only in 5. All cell lines have the expression of both genes.BMC Cancer 2006, 6:40 http://www.biomedcentral.com/1471-2407/6/40
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transcription factor and downstream target of β-catenin
[31]. SOX9 may thus be a potential target gene for prog-
nostic assessment and therapeutic intervention in colorec-
tal cancers.
Conclusion
In this study, genome-wide transcriptome overview of
colorectal cancers and their precursors were mined from
dbEST using an in-house GetUni software. Landscaping
the terrain of the transcriptome, new scopes in the initia-
tion and development of colon cancers were implicated.
We confirmed that colorectal cancers are genetically heter-
ogeneous. The interactive network among these genes in
colorectal cancers became more complicated due to fre-
quent alternative splicing. Aberrations of the ribosome
and glycolysis pathway might be early indicators of pre-
cursor lesions in colon cancers. Thus, the electronic gene
expression profile could be used to highlight the integral
molecular events in colorectal cancers. However, more
effort should be put into elucidating the regulatory net-
work among these genes via a strategy of system biology,
integrating colorectal specific gene expression microarray,
microfluidic card Q-PCR and proteomics study.
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